Hearing: “The Future of Medicine: Legislation to Encourage Innovation and Improve Oversight”

Subcommittee on Health (Committee on Energy and Commerce)

2123 RHOB
Washington, D.C.

Witnesses

Text of Legislation

• H.R. 1730, the “Speeding Therapy Access Today Act of 2021” [PDF]
• H.R. 2565, the “FDA Modernization Act of 2021” [PDF]
• H.R. 3085, the “Equity in Neuroscience and Alzheimer’s Clinical Trials Act of 2021” or the “ENACT Act of 2021” [PDF]
• H.R. 3927, the “Manufacturing API, Drugs, and Excipients in America Act” or the “MADE in America Act” [PDF]
• H.R. 4472, the “Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2021” or the “BENEFIT Act of 2021” [PDF]
• H.R. 4511, the “FDA Advancing Collection of Transformative Science Act” or the “FACTS Act” [PDF]
• H.R. 5030, the “Diversifying Investigations Via Equitable Research Studies for Everyone Trials Act” or the “DIVERSE Trials Act” [PDF]
• H.R. 5566, the “Finding Orphan-disease Remedies With Antifungal Research and Development Act of 2021” or the “FORWARD Act of 2021” [PDF]
• H.R. 5585, the “Advanced Research Project Agency–Health Act” or the “ARPA-H Act” [PDF]
• H.R. 6000, the “Cures 2.0 Act” [PDF]
• H.R. 6584, the “Diverse and Equitable Participation in Clinical Trials Act” or the “DEPICT Act” [PDF]
• H.R. 6888, the “Helping Experts Accelerate Rare Treatments Act of 2022” [PDF]
• H.R. 6963, the “Accelerated Approval Integrity Act of 2022” [PDF]
• H.R. 6972, the “Give Kids a Chance Act” [PDF]
• H.R. 6973, the “Enhanced Access to Affordable Medicines Act” [PDF]
• H.R. 6988, the “Drug Manufacturing Innovation Act” [PDF]
• H.R. 6996, the “Accelerating Access for Patients Act” [PDF]
• H.R. 7006, the “Improving the Nation’s Safe Pharmaceuticals and Excipients by Creating Tools for Inspecting and Overseeing Needed Supplies Act” or the “INSPECTIONS Act” [PDF]
• H.R. 7008, the “Pre-Approval Information Exchange Act” [PDF]
• H.R. 7032, the “Increasing Transparency in Generic Drug Applications Act” [PDF]
• H.R. 7035, the “Biologics Market Transparency Act” [PDF]
• H.R. 7047, a bill to amend title III of the Public Health Service Act with respect to the determination by the Secretary regarding certain biosimilar application elements, and for other purposes [PDF]

Support Documents

• Hearing Notice [PDF]
• Briefing Memo [PDF] Added 03/15/2022 at 01:27 PM
• Document for the Record - A statement from Representative Vern Buchanan of Florida [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A letter from Jeffrey Brown, Science Advisor for People for the Ethical Treatment of Animals [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A statement from the National Organization for Rare Disorders [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A statement from Representative Elaine G. Luria of Virginia [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A letter from Molly Guthrie, Senior Director of Public Policy and Advocacy for Susan G. Komen [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A statement from the American Academy of Neurology [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A statement from the Association of Clinical Research Organizations [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A letter from pediatric cancer advocacy organizations in support of H.R. 6972 [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A statement from Andrea Noda, Vice President of Health Care at Arnold Ventures [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A statement from Howard “Skip” Burris, President of the Association for Clinical Oncology [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A list of endorsements for H.R. 2565 submitted by the Center for a Humane Economy [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A document from EveryLife Foundation for Rare Diseases entitled, “A Community Vision for a Rare Disease Center of Excellence at the FDA” [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A Bloomberg op-ed entitled, “Congress Needs to Fix the FDA’s ‘Accelerated’ Drug-Approval Process” [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A letter from the leading pediatric cancer clinical and preclinical consortiums endorsing H.R. 6972 [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A statement from Matthew Rizzo, Chair of the American Brain Coalition [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A statement from the EveryLife Foundation for Rare Diseases [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - Testimony from Jim Corbett, CEO of Emulate, Inc. [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A letter from the Alzheimer’s Impact Movement and JDRF [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A letter from stakeholders in support of H.R. 5585 [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - Testimony from Beyond Celiac [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - Testimony from the National LGBT Cancer Network [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A letter from stakeholders on the Growth of Drug-Resistant Fungi Threatens Health in the U.S. [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A letter from the Valley Fever Institute at Kern Medical in support of H.R. 5566 [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A statement from Generation Patient [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A statement from the Generics Access Project [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A statement from the National Marrow Donor Program/Be The Match [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A statement from the Humane Society of the United States and Humane Society Legislative Fund [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A May 2021 letter from the EveryLife Foundation for Rare Diseases [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - Testimony from Dr. Paul A. Locke, Associate Professor at the Johns Hopkins Bloomberg School of Public Health, Department of Environmental Health and Engineering [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A statement from Representative Kevin McCarthy of California [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - Testimony from Dr. Gary Michelson, Founder and Co-Chair of the Michelson Center for Public Policy [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A statement from the National Brain Tumor Society [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - Testimony from Dr. Trivia Frazier, CEO of Obatala Sciences [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A letter from the Personal Care Products Council, the Humane Society Legislative Fund, and the Humane Society of the United States [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A statement from Rajarshi Banerjee, CEO of Perspectum [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A statement from Kristie Sullivan, Vice President of Research Policy for the Physicians Committee for Responsible Medicine [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A letter from 14 stakeholder groups in support of H.R. 7008 [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - Testimony from Dr. Hope R. Ferdowsian, President and CEO of Phoenix Zones Initiative [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A letter from Representative Nancy Mace of South Carolina [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - Testimony from the International Autoimmune Encephalitis Society [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - Testimony from Dr. J. Lowry Curley, Co-Founder and CEO of AxoSim Inc. [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - A statement from the Neuroscience Working Table [PDF] Added 04/28/2022 at 12:40 PM
• Document for the Record - Testimony from the Allergy & Asthma Network [PDF] Added 12/12/2022 at 11:28 AM
• Document for the Record - Testimony from the American Academy of Family Physicians [PDF] Added 12/12/2022 at 11:28 AM

Member Statements

• Opening Statement of Rep. Anna G. Eshoo, Chairwoman of the Subcommittee on Health [PDF] Added 03/18/2022 at 12:30 PM
• Opening Statement of Rep. Brett Guthrie, Ranking Member of the Subcommittee on Health [PDF] Added 03/18/2022 at 12:30 PM
• Opening Statement of Rep. Frank Pallone, Jr., Chairman of the Full Committee [PDF] Added 03/18/2022 at 12:30 PM
• Opening Statement of Rep. Cathy McMorris Rodgers, Ranking Member of the Full Committee [PDF] Added 03/18/2022 at 12:30 PM

Hearing Record

• Member Attendance [PDF] Added 03/18/2022 at 12:30 PM
• Preliminary Transcript [PDF] Added 04/28/2022 at 12:40 PM

First Published: March 10, 2022 at 04:01 PM
Last Updated: December 12, 2022 at 11:28 AM